J&J Medical Connect
Oncology
Oncology

This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

Epidemiology

Estimated new MM cases and deaths in the United States based on SEER database1

scroll band
Bone marrow Bone marrow
Estimated New Cases in 2025 36,110
% of All New Cancer Cases 1.8%
Estimated Deaths in 2025 12,030
% of All Cancer Deaths 1.9%
5-year Relative Survival
(2015-2021)
62.4%
Median Age at Diagnosis 69
  • MM primarily affects older patients; median age at diagnosis is 69 years1
  • In 2022, the estimated prevalence of MM was 192,144 people in the United States1
  • MM is the 3rd most common hematologic malignancy after lymphoma and leukemia2

Incidence rates by race, ethnicity, and sex

  • MM is more common in men than women1
  • It is also more common among Black individuals1
scroll band
Bone marrow
scroll band
Bone marrow

MM, multiple myeloma; SEER, Surveillance, Epidemiology, and End Results.

1. SEER Cancer Stat Facts: Myeloma. National Cancer Institute. Bethesda, MD. Accessed February 20, 2026. http://seer.cancer.gov/statfacts/html/mulmy.html. 2. Cancer Facts and Figures 2025. American Cancer Society. Accessed February 20, 2026. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2025/2025-cancer-facts-and-figures-acs.pdf.

Would you like to clear and leave your conversation? Message history will be lost.